$41.63
0.982.41%
At close: Nov 13, 4:00 PM EST
$41.44
-0.19-0.46%
After Hours: 7:59 PM EST
Novo Nordisk AS (NVO) Stock Price, Quote, News & History
NVONYSE
Novo Nordisk secures EU approval for hemophilia therapy Frehemgo and submits US and European applications for sickle cell drug etavopivat.
You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.
Other companies in Novo Nordisk’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Novo Nordisk has a consensus price target of $83.69.
The stock price for Novo Nordisk (NYSE: NVO) is $41.44 last updated November 13, 2026 at 7:59 PM EST.
There are no upcoming dividends for Novo Nordisk.
Novo Nordisk does not have any upcoming earnings scheduled.
There is no upcoming split for Novo Nordisk.
Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients...
